Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

BioMarin Pharma sees big things for first FDA-approved dwarfism drug – MedCity News,

Other companies are aiming to challenge BioMarin in achondroplasia. A peptide drug from Ascendis Pharma is in mid-stage clinical development. Pfizer …, Other companies are aiming to challenge BioMarin in achondroplasia. A peptide drug from Ascendis Pharma is in mid-stage clinical development. Pfizer …, Read More

Scroll to Top